Skip to main content
Clinical Trials/CTRI/2022/03/041115
CTRI/2022/03/041115Not yet recruitingPhase 4

Comparison of intravenous Lignocaine with intravenous Lignocaine and Magnesium sulphate combination for laparoscopic Nephrectomy

Indhira gandhi institue of medical sciencePatna1 site in 1 country100 target enrollmentStarted: January 4, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
quality of recovery score

Study Overview

Brief Summary

The study is  taken to compare the management of pain in post laparoscopic Nephrectomy with the combination of intravenous Lignocaine and the combination of intravenous Lignocaine and magnesium sulphate for better pain control during the post operative period

Study Design

Study Type
Observational

Eligibility Criteria

Ages
1.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Elective laparoscopic Nephrectomy.

Exclusion Criteria

  • •1 Refused consent, 2 Allergic to local anaesthetic agent and opiods 3 on long term analgesic to chronic pain 4 Impaired liver function 5 Has a history of arrhythmia 6 Viral marker reactive 7 Covid 19 positive.

Outcomes

Primary Outcomes

quality of recovery score

Time Frame: at 24 hr postoperative period

Secondary Outcomes

  • hemodynamics every 30 min after starting infusion.(NRS pain score)

Investigators

Sponsor
Indhira gandhi institue of medical sciencePatna
Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials